Glucophage XR
Showing 1 - 25 of 552
Healthy Trial in Darmstadt (Test Glucophage® XR, Reference Glucophage® XR)
Recruiting
- Healthy
- Test Glucophage® XR
- Reference Glucophage® XR
-
Darmstadt, GermanyResearch Site
Aug 10, 2022
Tendinopathy, Chronic Pain, Achilles Tendinopathy Trial in Pittsburgh (Metformin, Placebo)
Not yet recruiting
- Tendinopathy
- +2 more
- Metformin
- Placebo
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Oct 19, 2023
Healthy Trial in Daejeon (Glucophage® XR Test, Glucophage® XR Reference)
Completed
- Healthy
- Glucophage® XR Test
- Glucophage® XR Reference
-
Daejeon, Korea, Republic ofClinical Trials Center, Chungnam National University Hospital
Mar 30, 2022
Fibromyalgia Syndrome Trial in Salt Lake City (Metformin, Placebo)
Active, not recruiting
- Fibromyalgia Syndrome
- Metformin
- Placebo
-
Salt Lake City, UtahUniversity of Utah
Jun 12, 2023
Healthy Volunteer Trial in Suzhou (Dapagliflozin/metformin XR FDC 5/500 mg, Dapagliflozin/metformin XR FDC 10/1000 mg,
Completed
- Healthy Volunteer
- Dapagliflozin/metformin XR FDC 5/500 mg
- +3 more
-
Suzhou, ChinaResearch Site
Apr 25, 2022
Pharmacokinetics Trial in Prague (Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine), Glucophage® XR 1000 mg
Completed
- Pharmacokinetics
- Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine)
- Glucophage® XR 1000 mg Prolonged Release Tablets
-
Prague, CzechiaQUINTA-ANALYTICA s.r.o.
Nov 17, 2021
Pharmacokinetics Trial in Prague (Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine), Glucophage® XR 1000 mg
Completed
- Pharmacokinetics
- Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine)
- Glucophage® XR 1000 mg Prolonged Release Tablets (Merck Serono Ltd, UK)
-
Prague, CzechiaQUINTA-ANALYTICA s.r.o.
Nov 9, 2021
Low Back Pain Trial in Pittsburgh, Wexford (Metformin, Placebo)
Active, not recruiting
- Low Back Pain
- Metformin
- Placebo
-
Pittsburgh, Pennsylvania
- +1 more
Oct 28, 2022
Pharmacokinetics Trial in Prague (Metformin 500mg prolonged release tablets (JSC Farmak, Ukraine), Glucophage® XR 500 mg
Completed
- Pharmacokinetics
- Metformin 500mg prolonged release tablets (JSC Farmak, Ukraine)
- Glucophage® XR 500 mg prolonged release tablets (Merck Serono Ltd, UK)
-
Prague, CzechiaQUINTA-ANALYTICA s.r.o.
Nov 17, 2021
PreDiabetes, Adult Children Trial in Memphis (Metformin, Digital Intervention)
Recruiting
- PreDiabetes
- Adult Children
- Metformin
- Digital Intervention
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Sep 27, 2022
Pharmacokinetics Trial in Prague (Metformin, prolonged-release tablets 500 mg (JSC Farmak, Ukraine), Glucophage® XR 500 mg
Completed
- Pharmacokinetics
- Metformin, prolonged-release tablets 500 mg (JSC Farmak, Ukraine)
- Glucophage® XR 500 mg prolonged release tablets (Merck Serono Ltd, UK)
-
Prague, CzechiaQUINTA-ANALYTICA s.r.o.
Nov 17, 2021
Prostate Cancer, Prostate Cancer Recurrent Trial in Mineola (Metformin Hydrochloride Extended Release 750mg)
Completed
- Prostate Cancer
- Prostate Cancer Recurrent
- Metformin Hydrochloride Extended Release 750mg
-
Mineola, New YorkWinthrop University Hospital
Feb 2, 2022
Plasminogen Activator Inhibitor-1 Deficiency, Cardiac Fibrosis Trial (Metformin Extended Release Oral Tablet)
Not yet recruiting
- Plasminogen Activator Inhibitor-1 Deficiency
- Cardiac Fibrosis
- Metformin Extended Release Oral Tablet
- (no location specified)
Aug 1, 2022
Genetics, Metabolism, Type 2 Diabetes Trial in Boston (Mixed Meal Tolerance Test, Metformin)
Active, not recruiting
- Genetics
- +2 more
- Mixed Meal Tolerance Test
- Metformin
-
Boston, MassachusettsMassachusetts General Hospital
Apr 4, 2022
Lung Carcinoma Trial in Aurora, Buffalo, Vancouver (Extended Release Metformin Hydrochloride)
Recruiting
- Lung Carcinoma
- Biopsy
- +4 more
-
Aurora, Colorado
- +2 more
Jan 28, 2023
Osteoarthritis, Knee, Post-traumatic Osteoarthritis, ACL Tear Trial in United States (Metformin, Placebo)
Not yet recruiting
- Osteoarthritis, Knee
- +2 more
- Metformin
- Placebo
-
Atlanta, Georgia
- +8 more
Oct 19, 2023
Melanoma, NSCLC, Hepatocellular Carcinoma Trial in Pittsburgh (Nivolumab or Pembrolizumab (dependent upon approved indication),
Recruiting
- Melanoma
- +7 more
- Nivolumab or Pembrolizumab (dependent upon approved indication)
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Feb 10, 2022
Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in United States (Metformin XR, Placebo)
Recruiting
- Monoclonal Gammopathy of Undetermined Significance
- Smoldering Multiple Myeloma
- Metformin XR
- Placebo
-
Boston, Massachusetts
- +6 more
Oct 3, 2022
Type 2 Diabetes, High Blood Pressure, Arthritis Trial in Albany (Metformin, Val, Cel and Met XR Low, Val, Cel and Met XR High)
Not yet recruiting
- Type 2 Diabetes
- +3 more
- Metformin
- +2 more
-
Albany, New YorkAlbany Medical College
Dec 28, 2020
DLBCL Trial in Chicago (Metformin, Rituximab, Cyclophosphamide)
Terminated
- Diffuse Large B-Cell Lymphoma
- Metformin
- +6 more
-
Chicago, IllinoisRush University Medical Center
Aug 24, 2021
Type 2 Diabetes Trial in Nakhon Pathom (Gemigliptin tartrate sesquihydrate and metformin, gemigliptin 50 mg and metformin HCl
Completed
- Type 2 Diabetes
- Gemigliptin tartrate sesquihydrate and metformin
- gemigliptin 50 mg and metformin hydrochloride 1000 mg prolonged release
-
Nakhon Pathom, ThailandInternational Bio Service Co., Ltd.
Feb 4, 2021
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Ductal Carcinoma In Situ Trial in
Not yet recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +3 more
- Biospecimen Collection
- +4 more
-
Houston, Texas
- +2 more
Aug 17, 2022
Healthy Volunteers Trial in Kajetany (CPL207280, Placebo, Metformin HCl 750 mg)
Completed
- Healthy Volunteers
- CPL207280
- +2 more
-
Kajetany, Nadarzyn, PolandBioResearch Group Sp. z o.o.
Aug 17, 2021
Healthy Volunteers Trial in Overland Park (Emraclidine, Itraconazole, Carbamazepine)
Recruiting
- Healthy Volunteers
- Emraclidine
- +3 more
-
Overland Park, KansasOverland Park, Kansas
Jul 20, 2023
Head and Neck Squamous Cell Carcinoma Trial in Cincinnati (Metformin Extended Release Oral Tablet, Pembrolizumab)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Metformin Extended Release Oral Tablet
- Pembrolizumab
-
Cincinnati, OhioUniversity of Cincinnati Medical Center
Sep 15, 2021